Showing results (71-80 of 170) with videos related to
Sort By:
Pageof 17
Annals of Internal Medicine|February 1, 1975
Type III hyperlipoproteinemia: an analysis of two contemporary definitionsD S Fredrickson, J Morganroth, R I LevyAnnals of Internal Medicine|February 1, 1975
The biochemical, clinical, and genetic features of type III hyperlipoproteinemiaJ Morganroth, R I Levy, D S FredricksonClinical Pharmacology and Therapeutics|December 17, 2009
Evaluation and management of cardiac safety using the electrocardiogram in oncology clinical trials: focus on cardiac repolarization (QTc interval)J Morganroth, R R Shah, J W ScottAnnals of Internal Medicine|September 1, 1976
Cholestyramine: an effective, twice-daily dosage regimenC B Blum, R J Havlik, J MorganrothClinical Cardiology|July 1, 1981
Large Mobile pedunculated left ventricular thrombus: identification by two-dimensional echocardiographyC C Chen, G W Webster, J MorganrothCatheterization and Cardiovascular Diagnosis|January 1, 1984
Determinants of outcome following left ventricular aneurysmectomyP F Nestico, A H Hakki, A S Iskandrian, et al.Circulation|October 1, 1989
Mechanisms and risk factors for proarrhythmia with type Ia compared with Ic antiarrhythmic drug therapyJ H Levine, J Morganroth, A H KadishAnnals of Internal Medicine|September 1, 1985
Tocainide: a new oral antiarrhythmic agentS P Kutalek, J Morganroth, L N HorowitzAnnals of Internal Medicine|June 1, 1980
Nonsustained ventricular tachycardia in ambulatory patients: characteristics and association with sudden cardiac deathW P Follansbee, E L Michelson, J MorganrothCirculation|June 1, 1983
Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experienceE Lichstein, J Morganroth, R Harrist, et al.Pageof 17